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Abstract
Background: Enterovirus (EV)-related hand, foot, and mouth disease/herpangina (HFMD/HA) has been prevalent in
Guangdong Province, China, since 2010.
Methods: Clinical data for EV-related HFMD/HA inpatients admitted to the Department of Paediatrics of Zhujiang
Hospital from 2010 to 2013 were retrospectively reviewed. The corresponding EV serotypes were also determined
by reverse transcription-polymerase chain reaction or BLAST analysis of the sequenced partial lengths of the viral
protein1/5′-untranslated region.
Results: A total of 867 eligible inpatients admitted during 2010–2013 were included in the study. Of these,
the serotype of the responsible EV was successfully identified in 824 cases. The incidence of enterovirus 71
(EV71) infection amongst pediatric HFMD/HA inpatients decreased dramatically from 55.5 % in 2010 to 8.1 %
in 2013, with a similar decrease recorded for coxsackievirus A16 (CVA16). However, the incidence of non-EV71/
CVA16 infection increased from 30.0 % in 2010 to 83.8 % in 2013. We noted that the types of infection caused by
different EV serotypes varied: EV71 was responsible for 100 % of the paralysis cases (26/26), 84.6 % of the deaths
(11/13), and 84.1 % of cases with severe central nervous system involvement (SCNSI) (74/88); echovirus contributed
to 16.4 % of the deaths (2/13) and 4.4 % of the SCNSI cases; and coxsackievirus accounted for only 2.2 % of the SCNSI
cases (2/90). The clinical features of HFMD/HA cases varied greatly during the time period examined, with drastic
changes in the hospitalization rates (45.1, 63.7, 36.4, and 19.1 % for 2010, 2011, 2012, and 21013, respectively), mortality
rates (2.3, 0.9, 2.5, and 0.0 %, respectively), paralysis (5.1, 1.2, 5.4, and 0.0 %, respectively), SCNSI (16.8, 7.1, 12.7, and 2.2 %,
respectively), and acute respiratory infection (21.1, 22.0, 45.9, and 59.0 %, respectively).
Conclusions: The incidences of infection caused by different EV serotypes, along with the clinical features of HFMD/HA
cases, changed drastically in Guangdong Province, China, from 2010 to 2013, with the biggest changes observed in
2013. The changed constituent ratios of the different EV serotypes might therefore be responsible for the differences
in the observed clinical features of HFMD/HA during this period.
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Background
Many enterovirus (EV) serotypes, including EV71, cox-
sackievirus A (CVA2, 4, 5, 7, 9, 10, 16), and coxsackievirus
B (1, 2, 3, 4, 5), have been reported to cause hand, foot
and mouth disease/herpangina (HFMD/HA) in humans.
Of these, EV71 and CVA16 have traditionally been the
two most common serotypes in mainland China [1–6]. In
addition to fever and a rash, respiratory infection, hepatic
injury, myocardial injury, meningitis, encephalitis, and
acute flaccid paralysis are observed in EV-related HFMD/
HA [7–9]. Different serotypes of EV mutually overlap in
disease causation, and no serotype is assigned to a particu-
lar disease. However, some serotypes are more associated
with particular diseases, such as EV71, which is associated
with neurogenic pulmonary edema, brainstem encephal-
itis, and myelitis in young children [10–13]. The constitu-
ent ratios of EV serotypes change without cessation on a
global basis, and monitoring their associated changes in
the constituent ratios of circulating EV serotypes and their
associated diseases is essential for public health and effi-
cient allocation of medical resources.
Mainland China is heavily affected by EV-related
HFMD/HA, which has caused millions of infections and
hundreds of deaths annually since 2009 [14]. Guangdong,
a southern province of China, is one of the most severely
affected regions [15–17]. Zhujiang Hospital is an officially
assigned tertiary hospital for treating HFMD patients
in Guangzhou (the provincial capital of Guangdong
Province), as well as referral patients from other regions of
Guangdong Province. Using a retrospective analysis of clin-
ical information regarding HFMD/HA patients admitted to
Zhujiang Hospital with an ascertained EV serotype, the
current study aimed to elucidate the serotype constituent
evolution of EV, and to explore its effect on HFMD/HA in
Guangdong Province, China, between 2010 and 2013.
Methods
Patients and clinical data
A retrospective study was performed using pediatric pa-
tients with HFMD/HA admitted to Zhujiang Hospital
between January 2010 and December 2013. All cases
were from Guangzhou, or were referrals from other re-
gions of Guangdong Province. Pediatric patients fitting
the following criteria were included in the study: real-
time fluorescence reverse transcription (RT)-polymerase
chain reaction (PCR) evidence of positive EV; signs of
eruptions or fever; and younger than 16 years of age. To
reduce interference from other diseases, inpatients with
a medical history of on-going neurological symptoms,
congenital heart disease, or obvious bacterial infection
were excluded. The clinical records of each inpatient
were retrospectively itemized by two researchers, and
then confirmed by pediatric clinicians. Patient privacy
was maintained as the cases remained anonymous. The
study was approved by the Ethics Committee of Zhujiang
Hospital (ratification no.: ZJYY-2013-YXJYZX-001).
Stool sample collection and molecular analysis
A stool specimen was collected from each patient as part
of standard care, and RNA was extracted from a 140-μL
aliquot using a QIAamp Viral RNA Mini Kit (Qiagen,
Hilden, Germany) within 1 day of collection. Some of the
extracted RNA was used for immediate PCR analysis,
while the remaining stool specimen and RNA were stored
at −80 °C. Extracted RNA samples were used for real-time
fluorescence RT-PCR and/or amplification of partial
lengths of the viral protein 1/5′-untranslated region (VP1/
5′-UTR). EV71 and CVA16 were jointly identified using
EV71 and CVA16 EV kits (Shanghai ZJ Bio-Tech Co., Ltd,
Shanghai, China). The serotypes of non-EV71 and non-
CVA16 strains were initially determined by amplification
of a partial length of VP1, with further amplification of a
partial length of the 5′-UTR if necessary for clarification.
The VP1/5′-UTR fragments were amplified as described
previously [18, 19]. The products were sequenced by the
Huada Gene Company (Shenzhen, China), and then ana-
lyzed using the BLAST program against sequences avail-
able in the GenBank database to identify the serotype.
Clinical definitions
Central nervous system involvement (CNSI) cases were
defined as having two or more of the following: vomit-
ing, irritability, startle reflex, convulsion, changed mus-
cular tension, decreased tendon reflex, headache, neck
stiffness, or any sign of altered consciousness. Paralysis
and central nervous system lesions (on neuroimaging)
were categorized as severe central nervous system in-
volvement (SCNSI). Acute respiratory infection (ARI)
was diagnosed by the presence of rhinorrhea and/or
cough, and patients with pneumonia or bronchopneu-
monia were categorized as having a severe ARI. Acute
myocardial injury was diagnosed based on laboratory
evidence of elevated cardiac troponin I (cTnI), elevated
creatine kinase-MB (CK-MB), and anelevated CK-MB/
CK ratio. The following values were considered the
threshold over which the readings were considered ele-
vated: cTnI >0.04 μg/L, CK-MB/CK >0.25, CK-MB >44
U/L (2–36 month), CK-MB >37 U/L (37–72 month),
and CK-MB >31 U/L (>73 month). Patient with an ala-
nine aminotransferase level of >40 U/L was deemed as
having acute hepatic injury. Diarrhoea was defined as
presenting changed consistency of stool or frequency of
defecation ≥3 times/day.
Statistical analysis
Statistical analysis was performed using SPSS version 13.0
software (SPSS Inc., Chicago, IL, USA). The differences in
the categorical variables were analyzed by chi-square test.
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All tests were two-sided, and p < 0.05 was considered sta-
tistically significant.
Results
A total of 2394 EV-related HFMD/HA patients were
admitted to the Department of Paediatrics of Zhujiang
Hospital during the study period, consisting of 926 inpa-
tients and 1468 outpatients, and 824 inpatients were ascer-
tained infected EV serotype by PCR and/or sequencing.
Numbers of inpatients infected with EV71, CVA16 or non-
EV71/CVA16 were 390, 127 and 409, respectively; while
those of outpatients were 308, 259 and 901, correspond-
ingly. Of the 926 inpatients, 867 were deemed eligible and
were included in the current study (2010 (212), 2011 (314),
2012 (201), 2013 (140)), and the numbers of eligible inpa-
tients infected with EV71, CVA16 or non-EV71/CVA16 in-
cluded to illustrate the clinical features of HFMD/HA were
384, 120 and 363, respectively. The EV serotypes were suc-
cessfully ascertained from 320/363 inpatients with non-
EV71/CVA16 infection, of which the numbers of cases
identified by partial VP1 and 5′-UTR sequencing were 295
and 25, respectively. Amongst the 320 identified EV sero-
types, CVA6, CVA4, CVA10, echoviruses, and other cox-
sackieviruses accounted for 209 (65.3 %), 19 (5.9 %), 39
(12.2 %), 17 (5.3 %), and 36 (11.3 %) of the cases, respect-
ively. CVA6 was responsible for more than half of the non-
EV71/CVA16 cases each year during the study period as
follows: 64.4 % (2010), 58.3 % (2011), 54.5 % (2012), and
83.5 % (2013) (Fig. 1). Of the 17 sporadic cases of echo-
virus, 14 were admitted in 2012, with the remaining three
patients admitted in 2010 and 2011.
Significant changes occurred in the constituent ratios of EV
serotypes in Guangdong Province between 2010 and 2013
The constituent ratios of inpatients infected with
EV71, CVA16, and non-EV71/CVA16 changed greatly
between 2010 and 2013 (Fig. 2). The incidence of EV71-
infected inpatients decreased from 55.5 % in 2010 to 8.1 %
in 2013, with the incidence of CVA16 infection dropping
from 14.5 % in 2010 to 8.1 % in 2013. In contrast, the
incidence of non-EV71/CVA16 infection increased
from 30.0 % in 2010 to 83.8 % in 2013. Figure 2 shows
similar changes in the constituent ratios of outpatients
infected with EV71, CVA16, and non-EV71/CVA16.
Statistially significant differences were observed in the
constituent ratios of EV serotypes in outpatients
amongst these years (2011 vs 2012 (p = 0.029), others
(p < 0.01)), and statistially significant differences also
observed in inpatients amongst these years (p < 0.05),
except for 2010 vs 2011 (p =0.966).
Clinical features of HFMD/HA infection changed during
the study period
The clinical features of children with HFMD/HA varied
greatly over the study period. The hospitalization rate
for HFMD/HA cases decreased from 63.7 % in 2010 to
19.1 % in 2013, while the rates of mortality, paralysis,
SCNSI, and CNSI fluctuated drastically between 2010
and 2013 (Fig. 3). Additionally, ARI gradually replaced
CNSI as the leading complication of HFMD/HA (Fig. 3).
The risk of HFMD/HA sharply declined in 2013, with
decreasing incidences of CNSI and SCNSI and no occur-
rences of paralysis or death.
Fig. 1 Constituent ratios infections with CVA4, CVA6, CVA10, other coxsackieviruses or Echovirus in 320 genotying cases between 2010 and 2013.
Cox: coxsackieviruses
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The risks of severe complications of HFMD/HA varied
depending on EV serotype
Of the 824 cases with an ascertained EV serotype (EV71
(n = 384, 46.6 %), coxsackievirus (n = 423, 51.3 %), and
echovirus (n = 17, 2.1 %)), the mortality rates and neuro-
logical complications were disproportionately high in in-
fections caused by EV71 and echoviruses, while severe
complications were relatively low in cases caused by cox-
sackievirus. EV71 was responsible for 100 % of the par-
alysis cases (26/26), 84.6 % of the deaths (11/13), and
82.2 % of the cases of SCNSI (74/90), echovirus was re-
sponsible for 16.4 % of the deaths (2/13) and 4.4 % of
the cases of SCNSI, while coxsackievirus was responsible
for only 2.2 % of the cases of SCNSI (2/90), without
causing death or paralysis.
Discussion
This retrospective study demonstrated that the constitu-
ent ratios of EV serotypes in Guangdong Province, China,
changed significantly between 2010 and 2013. EV71 was
the predominant serotype at the beginning of the study
period, but was less prevalent by 2013, with the reverse
trend observed for CVA6. By 2013, EV71 infections
accounted for less than 10 % of cases, whereas non-EV71/
CVA16 serotypes caused more than 80 % of infections
(Fig. 2). The overwhelming majority of non-EV71/CVA16
infections were caused by CVA6, indicating that CVA6
was the predominant serotype in Guangdong Province in
2013. Two previous studies also confirmed that CVA6 had
become the dominant serotype in Guangdong during late
2012 and 2013 [17, 20], with similar reports from other re-
gions of China in 2013 [21, 22]. CVA6 also replaced EV71
as the dominant serotype in other areas of the Asia-Pacific
region, such as Taiwan, Thailand and Janpan in recent
years [23–25]. The underlying mechanisms driving
the shift of EV serotype constituent in an area maybe
caused by the declining number of susceptible popu-
lation caused by previous dominated serotype circula-
tion and genetic mutation of certain EV serotype
gaining edges on circulation.
Our data also showed that the drastically changed con-
stituent ratios of the EV serotypes fundamentally altered
the clinical features associated with HFMD/HA in
Guangdong Province during the same time period. Over-
all, the hospitalization rate declined substantially, from
45.1 % in 2010 to 19.1 % in 2013, with the rates of
SCNSI, paralysis, and death also declining, apart from a
rebound in 2012. The incidence of ARI increased over
the 4-year period, and became the most common com-
plication of HFMD/HA in 2012 and 2013 (Fig. 3). The
risk of severe complications of HFMD/HA significantly
deceased in 2013, with only three inpatients developing
Fig. 2 Constituent ratios of children infected with EV71, CVA16, or non-EV71/CVA16 admitted to Zhujiang Hospital between 2010 and 2013.
Non-EV71/CVA16: non-enterovirus 71 and non-coxsackievirus A16; IP: inpatient; OP: outpatient; EV71: enterovirus 71; CVA: coxsackievirus A
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SCNSI, and no cases of paralysis or death. This decline
was predominantly caused by the decreased constituent
ratio of EV71 infections and the increased prevalence of
coxsackievirus infection, which causes less severe clinical
features in HFMD/HA patients. In agreement with our
results, EV71 was repeatedly reported to be responsible
for most of the cases resulting in death, encephalitis, or
paralysis in HFMD epidemics in the Asia-Pacific region
[10–13], whereas the two most common coxsackievirus
serotypes, i.e., CVA6 and CVA16, were generally mild
with low incidences of SCNSI and death in children
[1, 25–27]. Low incidence of diarrhea in HFMD/HA
inpatients was observed in each year, which is some-
how akin to previous studies [28, 29].
Echovirus was shown to match the capacity of EV71
for causing death and SCNSI (the 17 echovirus infec-
tions contributed to 16.4 % of deaths and 4.4 % of the
cases of SCNSI), although its relatively low constituent
ratio (2.1 %) reduced its influence on the clinical features
of HFMD/HA in Guangdong Province over the study
period. The two deaths were infected with Echo 2 and
Echo 3, respectively; while the four SCNSI cases infected
by Echo 2 (2 cases), Echo 3 (1 case) and Echo 1 (1 case)
(data not shown). However, a cluster of echovirus infec-
tions contributed to the increase in mortality rates and
SCNSI in 2012. Therefore, we concluded that the re-
duced prevalence of EV71 and the increase in coxsackie-
virus infections were responsible for the changes in
clinical features associated with HFMD/HA between
2010 and 2013. In accordance with our results, other
countries or regions that experienced a declined threat
of HFMD/HA also documented a decrease in EV71 in-
fections and an increase in coxsackievirus infections.
Because this study constitutes a retrospective analysis
of patients admitted to an officially designated HFMD
hospital that treats patients from the provincial capital
Fig. 3 Evolution of the clinical features of HFMD/HA inpatients admitted to Zhujiang Hospital between 2010 and 2013. SCNSI: severe central
nervous system involvement; HFMD/HA: hand, foot, and mouth disease/herpangina; CNSI: central nervous system involvement; ARI: acute respiratory
infection; SARI: severe acute respiratory infection; AMI: acute myocardial injury; AHI: acute hepatic injury. Title: the relationship of enterovirus serotype
constituent ratios and the clinical features of infected children. We observed the phenomneon of obvious change of clinical features of children
infected with enterovirus and a notable change of enterovirus serotype constituent ratios in Guangdong province, China during 2010–2013, which
suggested that change of enterovirus serotype constituent ratios might be responsible for the phenomenon of obvious change of clincial features of
children infected with enterovirus
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and referrals from other regions of Guangdong Province,
there is an inherent bias in the study results. Addition-
ally, bias might be generated by uneven patient distribu-
tion from the different districts, which might affect the
degree to which the clinical features and serotype con-
stituent ratios for EV-related HFMD/HA in Guangdong
Province between 2010 and 2013 are represented.
Conclusions
Our study demonstrated that EV71 was the predominant
serotype in Guangdong Province at the beginning of the
study period, but had declined in prevalence by 2013. In
comparison, the incidence of CVA6 infections signifi-
cantly increased over the same period, with CVA6 be-
coming the dominant serotype in 2013. Additionally, our
data suggested that the changed constituent ratios of the
EV serotypes might have influenced the clinical features
of HFMD/HA infection in Guangdong Province, China,
from 2010 to 2013.
Additional files
Additional file 1: Sequence data of non-EV71/CVA16 enterovirus isolated
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